BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38937771)

  • 1. Acceptability of artificial intelligence for cervical cancer screening in Dschang, Cameroon: a qualitative study on patient perspectives.
    Sachdeva M; Datchoua AM; Yakam VF; Kenfack B; Jonnalagedda-Cattin M; Thiran JP; Petignat P; Schmidt NC
    Reprod Health; 2024 Jun; 21(1):92. PubMed ID: 38937771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "Cervical cancer screening: awareness is not enough". Understanding barriers to screening among women in West Cameroon-a qualitative study using focus groups.
    Datchoua Moukam AM; Embolo Owono MS; Kenfack B; Vassilakos P; Petignat P; Sormani J; Schmidt NC
    Reprod Health; 2021 Jul; 18(1):147. PubMed ID: 34243778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Barriers to cervical cancer prevention in rural Cameroon: a qualitative study on healthcare providers' perspective.
    Roux AN; Kenfack B; Ndjalla A; Sormani J; Wisniak A; Tatrai K; Vassilakos P; Petignat P; Schmidt N
    BMJ Open; 2021 Jun; 11(6):e043637. PubMed ID: 34140340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "My motivation was to save": a qualitative study exploring factors influencing motivation of community healthcare workers in a cervical cancer screening program in Dschang, Cameroon.
    Hämmerli P; Moukam AD; Wisniak A; Sormani J; Vassilakos P; Kenfack B; Petignat P; Schmidt NC
    Reprod Health; 2022 Jun; 19(1):133. PubMed ID: 35668427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study protocol for a two-site clinical trial to validate a smartphone-based artificial intelligence classifier identifying cervical precancer and cancer in HPV-positive women in Cameroon.
    Baleydier I; Vassilakos P; Viñals R; Wisniak A; Kenfack B; Tsuala Fouogue J; Enownchong Enow Orock G; Lemoupa Makajio S; Foguem Tincho E; Undurraga M; Cattin M; Makohliso S; Schönenberger K; Gervaix A; Thiran JP; Petignat P
    PLoS One; 2021; 16(12):e0260776. PubMed ID: 34914727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Internal validation of Automated Visual Evaluation (AVE) on smartphone images for cervical cancer screening in a prospective study in Zambia.
    Hu L; Mwanahamuntu MH; Sahasrabuddhe VV; Barrett C; Horning MP; Shah I; Laverriere Z; Banik D; Ji Y; Shibemba AL; Chisele S; Munalula MK; Kaunga F; Musonda F; Malyangu E; Hariharan KM; Parham GP
    Cancer Med; 2024 Jun; 13(11):e7355. PubMed ID: 38872398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Providers and women's perspectives on opportunities, challenges and recommendations to improve cervical cancer screening in women living with HIV at Mbarara Regional Referral Hospital: a qualitative study.
    Agaba CD; Namuli A; Ainomugisha B; Tibaijuka L; Ninsiima M; Ngonzi J; Akatukwasa C; Owaraganise A
    BMC Womens Health; 2024 Jul; 24(1):392. PubMed ID: 38978020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acceptability and implementation challenges of smartphone-based training of community health nurses for visual inspection with acetic acid in Ghana: mHealth and cervical cancer screening.
    Asgary R; Cole H; Adongo P; Nwameme A; Maya E; Adu-Amankwah A; Barnett H; Adanu R
    BMJ Open; 2019 Jul; 9(7):e030528. PubMed ID: 31315879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perspectives of women participating in a cervical cancer screening campaign with community-based HPV self-sampling in rural western Kenya: a qualitative study.
    Oketch SY; Kwena Z; Choi Y; Adewumi K; Moghadassi M; Bukusi EA; Huchko MJ
    BMC Womens Health; 2019 Jun; 19(1):75. PubMed ID: 31196175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of an educational intervention on women's knowledge and acceptability of human papillomavirus self-sampling: a randomized controlled trial in Cameroon.
    Sossauer G; Zbinden M; Tebeu PM; Fosso GK; Untiet S; Vassilakos P; Petignat P
    PLoS One; 2014; 9(10):e109788. PubMed ID: 25333793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acceptability of HPV screening among HIV-infected women attending an HIV-dedicated clinic in Abidjan, Côte d'Ivoire.
    Mensah K; Assoumou N; Duchesne V; Pourette D; DeBeaudrap P; Dumont A
    BMC Womens Health; 2020 Jul; 20(1):155. PubMed ID: 32723350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Training, Supervision, and Competence Assessment of Cameroonian Health Care Providers Using HPV Self-Sampling, Triage by Visual Inspection, and Treatment by Thermal Ablation in a Single Visit.
    Frund C; Kenfack B; Sormani J; Wisniak A; Fouogue JT; Tincho E; Metaxas T; Vassilakos P; Petignat P
    Front Public Health; 2022; 10():875177. PubMed ID: 35419330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "The best thing is that you are doing it for yourself" - perspectives on acceptability and feasibility of HPV self-sampling among cervical cancer screening clients in Tanzania: a qualitative pilot study.
    Bakiewicz A; Rasch V; Mwaiselage J; Linde DS
    BMC Womens Health; 2020 Mar; 20(1):65. PubMed ID: 32234028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient Perspectives on the Use of Artificial Intelligence for Skin Cancer Screening: A Qualitative Study.
    Nelson CA; Pérez-Chada LM; Creadore A; Li SJ; Lo K; Manjaly P; Pournamdari AB; Tkachenko E; Barbieri JS; Ko JM; Menon AV; Hartman RI; Mostaghimi A
    JAMA Dermatol; 2020 May; 156(5):501-512. PubMed ID: 32159733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Barriers and facilitators to cervical cancer screening uptake among women in Nepal - a qualitative study.
    Greibe Andersen J; Shrestha AD; Gyawali B; Neupane D; Kallestrup P
    Women Health; 2020 Oct; 60(9):963-974. PubMed ID: 32643576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genital self-sampling for HPV-based cervical cancer screening: a qualitative study of preferences and barriers in rural Ethiopia.
    Brandt T; Wubneh SB; Handebo S; Debalkie G; Ayanaw Y; Alemu K; Jede F; von Knebel Doeberitz M; Bussmann H
    BMC Public Health; 2019 Jul; 19(1):1026. PubMed ID: 31366402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing the uptake of cervical cancer screening among women aged 25-65 years in Kumbo West Health District, Cameroon.
    Donatus L; Nina FK; Sama DJ; Nkfusai CN; Bede F; Shirinde J; Cumber SN
    Pan Afr Med J; 2019; 33():106. PubMed ID: 31489084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Barriers to Cervical Cancer Screening and Treatment in the Dominican Republic: Perspectives of Focus Group Participants in the Santo Domingo Area.
    Liebermann EJ; VanDevanter N; Shirazian T; Frías Gúzman N; Niles M; Healton C; Ompad D
    J Transcult Nurs; 2020 Mar; 31(2):121-127. PubMed ID: 31046602
    [No Abstract]   [Full Text] [Related]  

  • 19. Women's experiences with cervical cancer screening in a colposcopy referral clinic in Cape Town, South Africa: a qualitative analysis.
    Momberg M; Botha MH; Van der Merwe FH; Moodley J
    BMJ Open; 2017 Feb; 7(2):e013914. PubMed ID: 28213603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cervical pre-cancerous lesion detection: development of smartphone-based VIA application using artificial intelligence.
    Harsono AB; Susiarno H; Suardi D; Owen L; Fauzi H; Kireina J; Wahid RA; Carolina JS; Mantilidewi KI; Hidayat YM
    BMC Res Notes; 2022 Dec; 15(1):356. PubMed ID: 36463193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.